Cytokinetics
Prescription Drugs · Cardiometabolic Therapeutics
41open roles
$226kmedian advertised pay
5countries with offices
500+people
Overview
Cytokinetics is a specialty cardiovascular biopharmaceutical company headquartered in South San Francisco, California, that discovers and develops small-molecule muscle activators and inhibitors for diseases of impaired muscle function. Founded in 1997 by four muscle biology researchers, it is listed on Nasdaq and markets MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy, with a commercial office in Radnor, Pennsylvania and teams in the UK, Switzerland, France, Ireland and Spain. It hires field access managers, regulatory, quality, medical affairs and pharmacovigilance specialists, scientists and commercial leaders.
Key facts
As of Nov 13, 2026, Alion lists 41 open roles at Cytokinetics. Cytokinetics is headquartered in South San Francisco, United States. It was founded in 1997. The median pay stated in its open roles is $221k, across 38 postings that state pay.
- Open roles
- 41Job postings Alion tracks, as of Nov 13, 2026
- Headquarters
- South San Francisco, United StatesAlion company profile, updated Nov 13, 2026
- Founded
- 1997Alion company profile, updated Nov 13, 2026
- Employees
- 500+Alion company profile, an estimated range
- Median advertised pay
- $221kPay stated in 38 open postings
- Visa sponsorship, United States
- 6 ▼ 40% · H-1B filings in 12 monthsUS Department of Labor · latest filing Jun 25, 2026
- Technologies in its job postings
- 37Named in its job postings
Official records
Jobs
$181k – $211k per year · Equity · Remote (United States) · Full-Time · Bachelor's Degree · United States
GDPR
Analytics
Microsoft Excel
Apply
$230k – $268k per year · Equity · In office · Full-Time · 6+ years exp · South San Francisco
GDPR
Apply
$162k – $195k per year · Equity · Remote (United States) · Full-Time · 5+ years exp · Bachelor's Degree · United States
GDPR
Apply
$124k – $155k per year (gross) · Remote (Germany) · Full-Time · 8+ years exp · Germany
GDPR
MedTech
CAPA
Apply
$276k – $322k per year · Equity · In office · Full-Time · 3+ years exp · United States
GDPR
Apply
$182k – $212k per year · Equity · In office · Full-Time · 5+ years exp · PhD · South San Francisco
GDPR
Life Sciences
GMP
MedTech
CAPA
Apply
$162k – $189k per year · Equity · In office · Full-Time · 5+ years exp · PhD · South San Francisco
GDPR
Life Sciences
Mass Spectrometry
HPLC
Chromatography
GMP
Apply
$221k – $257k per year · Equity · Hybrid · Full-Time · 10+ years exp · Bachelor's Degree · Radnor
Python
SQL
AI Agents
LLM
Time Series
Recommender Systems
Machine Learning
DevOps
CI/CD
Cybersecurity
GDPR
Analytics
Tableau
Power BI
A/B Testing
Apply
$202k – $235k per year · Equity · In office · Full-Time · 8+ years exp · Bachelor's Degree · South San Francisco
Azure
AWS
Cybersecurity
GDPR
Management
SharePoint
Apply
$185k – $215k per year · Equity · In office · Full-Time · 4+ years exp · PhD · South San Francisco
Python
Machine Learning
DevOps
GCP
AWS
Cybersecurity
GDPR
Apply
≈ $110k – $306k per year (Estimated) · Equity · In office · Full-Time · 6+ years exp · PhD · South San Francisco
Python
AI Agents
LLM
Agentic Workflows
Cybersecurity
GDPR
Apply
$239k – $299k per year · In office · Full-Time · 8+ years exp · PhD · Zug
GDPR
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$226k
Typical range
$134k – $410k
Open positions
38
38
Jobs
Junior
5.3%
Middle
2.6%
Senior
36.8%
Staff
2.6%
Architect
52.6%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 2 | $150k | $142k – $158k |
| Middle | 1 | $173k | $173k |
| Senior | 14 | $205k | $134k – $410k |
| Staff | 1 | $150k | $150k |
| Architect | 20 | $263k | $183k – $394k |
Highest paying role
Senior Director, Medical Safety & Pharmacovigilance
$410k
Normalized to USD per year
All salaries at Cytokinetics
By role, level and city, against the market · 38 jobs with pay
Visa sponsorship
6 ▼ 40%
H-1B filings in 12 months
$143k
Median offered salary
34
Open roles in United States
Who they sponsor
Chemists
2
Compliance officers
1
Natural sciences managers
1
In the register as Cytokinetics, Inc., South San Francisco, CA (+1 more)
Other sponsors in the same field
Eli Lilly and Company 420 filings
Amgen 372 filings
Bristol Myers Squibb 218 filings
Novo Nordisk 39 filings
See 34 open roles Alert me
US Department of Labor · latest filing Jun 25, 2026 · Visa details by country
Growth
Hiring Momentum
45/100
Stable
Open positions
41
5 opened / 29 closed in 30 days
Median time-to-fill
58 days
faster than 23% of the market
ATS activity
Every ~10 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
28%
Marketing
10% ▼
Legal
9% ▲
Science & Research
9% ▼
QA
7% ▲
Finance
7% ▼
Actively hiring for Biotech (+6 in 30 days)
Activity Timeline
Added ICH Guidelines to stack
Oct 2026
Added Snowflake to stack
Oct 2026
Added Google BigQuery to stack
Oct 2026
Added Databricks to stack
Oct 2026
Added Azure to stack
Oct 2026
Added Time Series to stack
Oct 2026
Added SQL to stack
Oct 2026
Added Recommender Systems to stack
Oct 2026
Added CI/CD to stack
Oct 2026
Added AI Agents to stack
Oct 2026
Added A/B Testing to stack
Oct 2026
Added CAPA to stack
Oct 2026
Tech stack
Technologies named in job postings at Cytokinetics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
37
Postings analysed
46
Stack modernity
68/100AI adopter
Languages
Python11%
SQL4%
Databases
Google BigQuery2%
Oracle2%
Snowflake2%
Cloud & platforms
Power BI33%
Tableau9%
AWS7%
GCP7%
AI & ML
LLM11%
Sign in to see how your skills match this stack
Sign In
Full Cytokinetics tech stack
37 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Foresite CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Cytokinetics stock gains 2.15 percent as analysts target USD 109.90
Cytokinetics stock traded at USD 66.05 on September 28, 2026, while second-quarter revenue reached USD 28.6 million. Myqorzo sales rose to USD 25.3 million.
Read more
Report
Cytokinetics Maps MYQORZO Expansion, Heart Failure Pipeline at Bernstein Conference
Cytokinetics (NASDAQ:CYTK) executives outlined the company's commercial expansion plans, cardiovascular pipeline and business-development priorities during a Bernstein investor symposium, highlighting the launch of MYQORZO and clinical programs targeting
Read more
Report
Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story?
Polaris Capital Management, an investment management company, released its second-quarter 2026 investor letter for
Read more
Report
Cytokinetics stock steadies after recent data and guidance updates
Cytokinetics stock is trading on Nasdaq around recent levels as of September 19, 2026, after the company updated investors on trial progress and guidance in its latest quarterly figures. The biotech's recent revenue and loss metrics frame the risk-reward
Read more
Report
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 15, ...
Read more
Report
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
Program Provides Communications and Outreach Support for Patient Advocacy Organizations Focused on Cardiovascular DiseasesDeadline for Application...
Read more
Report
What This Cytokinetics Insider Sale Might Mean With the Stock Up 110%
Blum exercised options at $10.60 per share and immediately sold them at $82.02, capturing gains from a 122% stock surge over the past year. He retains 381,986 shares and maintains a 0.31% ownership stake.
Read more
Report
Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments
Shares of Cytokinetics, which targets medicines for specialty heart diseases, have jumped about 69% over the past three months and are up 31% year to date.
Read more
Report
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
--Cytokinetics, Incorporated today announced its intention to offer, subject to market conditions and other factors, $550.0 million aggregate principal amount of convertible senior notes due 2031 in a private placement to persons reasonably believed to be
Read more
Report
Offices
Where the company hires and what each office is for
Cities
6
Hiring now
4
Countries
5
Busiest office
South San Francisco
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
South San Francisco
United States
HQ
South San Francisco, CA (HQ)
24 open roles 31 posted in 90 days 17% engineering 500-1000 est. staff $237k Avg Salary
hires for Biotech, Science & Research, Leadership
350 Oyster Point Blvd, South San Francisco, CA 94080
Radnor
United States
Regional office
Radnor, PA
9 open roles 10 posted in 90 days 11% engineering 50-200 est. staff $232k Avg Salary
hires for Marketing, Biotech, QA
150 N Radnor Chester Rd, Suite C300, Wayne, PA 19087
Dublin
Ireland
Corporate office
Ireland
3 open roles 3 posted in 90 days 10-50 est. staff $193k Avg Salary
hires for Finance, Legal, Operations
Zug
Switzerland
Zug
1 open roles 4 posted in 90 days 10-50 est. staff $301k Avg Salary
hires for Biotech
London
United Kingdom
Regional office
London, United Kingdom
London W1U 6AG, United Kingdom
Boulogne-Billancourt
France
Regional office
Boulogne, France
92100 Boulogne-Billancourt, France
How to cite this page
Alion, "Cytokinetics: key facts", as of Nov 13, 2026. https://alion.io/company/cytokinetics
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0